[go: up one dir, main page]

WO1998040474A3 - Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung - Google Patents

Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung Download PDF

Info

Publication number
WO1998040474A3
WO1998040474A3 PCT/EP1998/001364 EP9801364W WO9840474A3 WO 1998040474 A3 WO1998040474 A3 WO 1998040474A3 EP 9801364 W EP9801364 W EP 9801364W WO 9840474 A3 WO9840474 A3 WO 9840474A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood factor
production
dependent blood
activated vitamin
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/001364
Other languages
English (en)
French (fr)
Other versions
WO1998040474A2 (de
Inventor
Peter Turecek
Guenter Richter
Anton Philapitsch
Hans-Peter Schwarz
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Priority to SK1246-99A priority Critical patent/SK124699A3/sk
Priority to HU0001505A priority patent/HUP0001505A3/hu
Priority to AU68295/98A priority patent/AU740727B2/en
Priority to EP98913692A priority patent/EP0968280A1/de
Priority to JP53920998A priority patent/JP2001514516A/ja
Priority to CA002284122A priority patent/CA2284122A1/en
Publication of WO1998040474A2 publication Critical patent/WO1998040474A2/de
Publication of WO1998040474A3 publication Critical patent/WO1998040474A3/de
Priority to NO994394A priority patent/NO994394L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Es wird ein Verfahren zur Aktivierung eines Vitamin K-abhängigen Blutfaktors beschrieben, wobei dies durch Behandlung mit einer Protease, die von Pflanzen oder Prokaryonten abgeleitet ist, erfolgt. Ausserdem umfasst die Erfindung den erfindungsgemäss hergestellten Blutfaktor, der keine Kontamination an tierischer Protease aufweist, sowie eine pharmazeutische Präparation und ein Set zur medizinischen Anwendung.
PCT/EP1998/001364 1997-03-12 1998-03-10 Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung Ceased WO1998040474A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SK1246-99A SK124699A3 (en) 1997-03-12 1998-03-10 Activated vitamin k-dependent blood factor and method for the production thereof
HU0001505A HUP0001505A3 (en) 1997-03-12 1998-03-10 Activated vitamin k-dependent blood factor and method for the production thereof
AU68295/98A AU740727B2 (en) 1997-03-12 1998-03-10 Activated vitamin K-dependent blood factor and method for the production thereof
EP98913692A EP0968280A1 (de) 1997-03-12 1998-03-10 Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung
JP53920998A JP2001514516A (ja) 1997-03-12 1998-03-10 活性化ビタミンｋ依存性血液因子およびその製造方法
CA002284122A CA2284122A1 (en) 1997-03-12 1998-03-10 Activated vitamin k-dependent blood factor and method for the production thereof
NO994394A NO994394L (no) 1997-03-12 1999-09-10 Aktivert vitamin K-avhengig blodfaktor og fremgangsmÕte for fremstilling av denne

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19710190A DE19710190A1 (de) 1997-03-12 1997-03-12 Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
DE19710190.9 1997-03-12

Publications (2)

Publication Number Publication Date
WO1998040474A2 WO1998040474A2 (de) 1998-09-17
WO1998040474A3 true WO1998040474A3 (de) 1999-02-11

Family

ID=7823110

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/001364 Ceased WO1998040474A2 (de) 1997-03-12 1998-03-10 Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung

Country Status (9)

Country Link
EP (1) EP0968280A1 (de)
JP (1) JP2001514516A (de)
AU (1) AU740727B2 (de)
CA (1) CA2284122A1 (de)
DE (1) DE19710190A1 (de)
HU (1) HUP0001505A3 (de)
NO (1) NO994394L (de)
SK (1) SK124699A3 (de)
WO (1) WO1998040474A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR102331A1 (es) * 2014-08-12 2017-02-22 Baxalta Inc Activación del factor x

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068047A2 (de) * 1981-06-25 1983-01-05 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundheilung
WO1991002065A1 (en) * 1989-08-11 1991-02-21 Zymogenetics, Inc. Cell culture methods for producing activated protein c
EP0443724A1 (de) * 1990-02-20 1991-08-28 Baxter International Inc. Gereinigtes, virusfreies menschliches Thrombin
WO1993006855A1 (en) * 1991-10-11 1993-04-15 Novo Nordisk A/S Hemostatic composition for local hemostasis
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
WO1993013208A1 (en) * 1991-12-31 1993-07-08 Zymogenetics, Inc. Methods for producing thrombin
DE4325872C1 (de) * 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
WO1994021284A1 (en) * 1993-03-15 1994-09-29 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
US5432062A (en) * 1992-04-06 1995-07-11 Immuno Aktiengesellschaft Method of proteolytically cleaving prothrombin to produce thrombin
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
US5514373A (en) * 1992-05-22 1996-05-07 Harris, Jr.; Roosevelt D. Topical preparation
WO1996023487A1 (de) * 1995-02-02 1996-08-08 Knoll Ag Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068047A2 (de) * 1981-06-25 1983-01-05 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundheilung
WO1991002065A1 (en) * 1989-08-11 1991-02-21 Zymogenetics, Inc. Cell culture methods for producing activated protein c
EP0443724A1 (de) * 1990-02-20 1991-08-28 Baxter International Inc. Gereinigtes, virusfreies menschliches Thrombin
WO1993006855A1 (en) * 1991-10-11 1993-04-15 Novo Nordisk A/S Hemostatic composition for local hemostasis
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
WO1993013208A1 (en) * 1991-12-31 1993-07-08 Zymogenetics, Inc. Methods for producing thrombin
US5432062A (en) * 1992-04-06 1995-07-11 Immuno Aktiengesellschaft Method of proteolytically cleaving prothrombin to produce thrombin
US5514373A (en) * 1992-05-22 1996-05-07 Harris, Jr.; Roosevelt D. Topical preparation
WO1994021284A1 (en) * 1993-03-15 1994-09-29 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
DE4325872C1 (de) * 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
WO1996023487A1 (de) * 1995-02-02 1996-08-08 Knoll Ag Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LAIDET B ET AL: "[Enzymatic debridement of leg ulcers using papain (letter)]. Detersion enzymatique des ulcères de jambe par la papaine.", ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, (1993) 120 (3) 248. JOURNAL CODE: 5RC. ISSN: 0151-9638., France, XP002075962 *
NAKAMURA S ET AL: "ON THE ACTIVATION OF BOVINE PLASMA FACTOR - XIII AMINO-ACID SEQUENCE OF THE PEPTIDE RELEASED BY THROMBIN AND THE TERMINAL RESIDUES OF THE SUBUNIT POLY PEPTIDES.", J BIOCHEM (TOKYO) 78 (6). 1975 (RECD 1976) 1247-1266. CODEN: JOBIAO ISSN: 0021-924X, XP002075961 *

Also Published As

Publication number Publication date
HUP0001505A3 (en) 2002-01-28
DE19710190A1 (de) 1998-09-17
NO994394L (no) 1999-11-11
SK124699A3 (en) 2000-06-12
EP0968280A1 (de) 2000-01-05
NO994394D0 (no) 1999-09-10
AU6829598A (en) 1998-09-29
JP2001514516A (ja) 2001-09-11
AU740727B2 (en) 2001-11-15
WO1998040474A2 (de) 1998-09-17
HUP0001505A1 (hu) 2000-09-28
CA2284122A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
BR0010657B1 (pt) composiÇço herbicida concentrada, composiÇço de tratamento de planta e mÉtodo para matar ou controlar o desenvolvimento de uma planta.
AU2003253175A1 (en) Process for the preparation of flavor or fragrance microcapsules
MXPA02010927A (es) Metodo y sistema para fabricar productos de tisu, y productos hechos por el mismo.
TW225532B (de)
DK0971600T3 (da) Medicinsk levnedsmiddel til diabetikere
WO2004075865A3 (en) Selective modulation of tlr-mediated biological activity
WO2001070197A3 (en) Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU2003297199A1 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
AU1865500A (en) Stabile and sterile emulsion which contains taxanes, and method for the production thereof
WO2002072848A3 (de) Erhöhung des vitamin-e-gehalts in organismen durch erhöhung der tyrosinaminotransferase-aktivität
WO2001005414A8 (en) Algae protein polysaccharide extraction and use thereof
WO1998040474A3 (de) Aktivierter vitamin k-abhängiger blutfaktor und verfahren zu dessen herstellung
WO2001096873A3 (en) Method for identifying apoptosis-modified proteins
WO2004078142A3 (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions
AU2003268706A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
AU2001277737A1 (en) Novel substance having physiological activity, process for producing the same, and use
HK1053103A1 (zh) 5-氨基-1-戊烯-3-醇取代的衍生物
AU2003246840A1 (en) Anti-hiv composition, production method thereof and medicament
WO1999053091A3 (de) Gdnf-kodierende dna, teile davon und gdnf-varianten
WO2005058889A3 (en) Biological active blood serum obtained by electrostimulation
AU3056099A (en) Method for searching physiologically active substances, process for producing theses substances and drugs found by the searching method
AU1021001A (en) Cyclic biphenyls, method for the production thereof, and their use as medicaments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT GH

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/008147

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: PV1999-3157

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2284122

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2284122

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 124699

Country of ref document: SK

Ref document number: 1998913692

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 1998 539209

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 68295/98

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998913692

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09380949

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: PV1999-3157

Country of ref document: CZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: PV1999-3157

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1998913692

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 68295/98

Country of ref document: AU